Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

The Next Generation in Aseptic-Filling Equipment

Adoption of single-use systems and more flexible systems drive innovation.
May 22, 2013

Adoption of single-use systems and more flexible systems drive innovation.

Raising the Bar in Tablet Coating Equipment and Processing

Greater automation and the adoption of solid versus perforated pans are some recent advances.
May 22, 2013

Greater automation and the adoption of solid versus perforated pans are some recent advances.

Multivariate Approaches for Powder Characterization

Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.
May 22, 2013

Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.

Liquid Nitrogen Cooling Systems Advantageous for Low-Temperature Chemical Synthesis

Access to extremely low and consistently controlled reaction temperatures can improve product yields and selectivities while also reducing costs.
May 22, 2013

Access to extremely low and consistently controlled reaction temperatures can improve product yields and selectivities while also reducing costs.

Optimizing the Selection of Mixing Equipment

Effective blenders provide efficient, homogeneous mixing and de-aeration for a wide range of formulations
May 8, 2013

Effective blenders provide efficient, homogeneous mixing and de-aeration for a wide range of formulations

Orally Disintegrating Technology Provides Both Formulating Challenges and Opportunities

Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.
May 8, 2013

Drug manufacturers today are increasingly challenged to find new, effective methods for the delivery of active pharmaceutical ingredients, and many are discovering that orally disintegrating technologies can help.

Improving the Economics of Monoclonal Antibody Separation

Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.
May 8, 2013

Advances in monoclonal antibody separation technologies are largely driven by the need to increase efficiencies and reduce cost.

Advances in Biodegradable Polymer Technologies Facilitate Sustained Release of Parenteral Drugs

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.
May 8, 2013

New platform technologies and polymer chemistries may facilitate self-administration, longer-term delivery, and targeted delivery of parenteral drugs.

Advances in Ion-Exchange Chromatography Leading to Increased Efficiencies and Reduced Costs

New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to eliminate process steps.
May 8, 2013

New ion-exchange chromatography media are more tolerant of varying conditions, making it possible to eliminate process steps.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here